FORA Capital LLC Sells 7,479 Shares of CME Group Inc. (NASDAQ:CME)

FORA Capital LLC trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 27.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,219 shares of the financial services provider’s stock after selling 7,479 shares during the quarter. FORA Capital LLC’s holdings in CME Group were worth $4,461,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CME. Harbor Capital Advisors Inc. raised its holdings in CME Group by 0.6% during the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after buying an additional 45 shares during the last quarter. CVA Family Office LLC increased its position in shares of CME Group by 11.8% during the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after acquiring an additional 46 shares in the last quarter. Lester Murray Antman dba SimplyRich raised its holdings in shares of CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after acquiring an additional 50 shares during the last quarter. Zions Bancorporation N.A. lifted its position in CME Group by 3.7% in the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after acquiring an additional 54 shares in the last quarter. Finally, Quent Capital LLC boosted its stake in CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after purchasing an additional 55 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Activity at CME Group

In related news, insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares in the company, valued at approximately $6,131,291.92. The trade was a 14.26 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,621 shares of company stock worth $3,441,063. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

CME has been the subject of several analyst reports. Oppenheimer increased their price objective on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Piper Sandler raised their price objective on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a research note on Tuesday, October 8th. Barclays increased their target price on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Finally, Morgan Stanley boosted their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $224.47.

CME Group Stock Performance

Shares of CME Group stock traded up $2.10 on Wednesday, reaching $236.49. 169,786 shares of the company traded hands, compared to its average volume of 1,918,892. The company has a 50 day moving average of $224.18 and a 200 day moving average of $211.37. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $237.11. The firm has a market capitalization of $85.22 billion, a PE ratio of 24.65, a PEG ratio of 5.29 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the business earned $2.25 earnings per share. CME Group’s revenue for the quarter was up 18.4% on a year-over-year basis. Equities analysts forecast that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 1.95%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is currently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.